Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Neoplasms × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 38 Radiotherapy 29 Pemetrexed 27 Docetaxel 25 Cisplatin 25 Paclitaxel 20 Gemcitabine 17 Nivolumab 15 Radiosurgery 12 Etoposide 12 pembrolizumab 10 Erlotinib Hydrochloride 10 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Vinorelbine 7 Radiation 7 Cyclophosphamide 6 Immunoglobulin G 5 Gefitinib 5 Disulfides 5 Dexamethasone 5 Chemotherapy, Adjuvant 5 Celecoxib 5 durvalumab 4 bintrafusp alfa protein, human 4 atezolizumab 4 Specimen Handling 4 Irinotecan 4 Interviews as Topic 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00801736 2013-12-10

ET

University College, London

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡